The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.

Discover how the genetics behind your eye color connects to various health conditions, from melanoma risk to pain ...

The company announced 27 abstracts at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting ...

Heidelberg Engineering, a global leader in ophthalmic imaging and healthcare data solutions, welcomes delegates at ARVO 2025 ...

The primary driver of this market expansion is the rising demand for vitrectomy procedures, a critical surgical intervention for treating a range of eye conditions, particularly those affecting the ...